Veronika Bridgman is the Co-Founder and CEO of Unravel Health, a London-based femtech company dedicated to closing the hormone data gap in women's health by bringing lab-grade diagnostics into the home.

With a BA in Advertising from OCAD University and a Certificate in Systems Thinking from Stanford Social Innovation, Veronika built a career as a Product and Innovation Strategy Director, leading teams for global brands including Canon, Visa, and E.ON.

Veronika's mission is deeply personal: she built her own hormone tracker fifteen years ago to manage PCOS after blood tests failed to illuminate her symptoms, and she co-founded Unravel to ensure no woman faces that gap again.

Before Unravel, Veronika served as an Impact Founder in Residence at Zinc and ran Triple Win Strategy, a product and innovation consultancy, while collaborating with governments, Fortune 500 companies, and startups to drive social impact.

Since co-founding Unravel in 2024 alongside CMO Dr. Alexandra Oti and CCO Liza Levy, the company has secured tech IP worth over £7M, raised a £2.5M pre-seed round led by Conduit EIS Impact Fund and Wrightwood, and is collaborating with researchers at King's College London, UCL, and Emory University.